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The mammalian ortholog of the Drosophila MOF (males absent on the first) gene product is a histone H4
lysine 16-specific acetyltransferase. Recent studies have shown that depletion of human MOF (hMOF) in
human cell lines leads to genomic instability, spontaneous chromosomal aberrations, cell cycle defects, altered
nuclear morphology, reduced transcription of certain genes, and defective DNA damage response to ionizing
radiation (IR). Here we show that MOF plays an essential role in mammals during embryogenesis and
oncogenesis. Ablation of the mouseMof gene (mMof) by gene targeting resulted in early embryonic lethality and
cell death. Lethality correlated with the loss of H4 lysine 16 acetylation (H4K16ac) and could not be rescued
by concomitant inactivation of ATM or p53. In comparison to primary cells or normal tissue, all immortalized
human normal and tumor cell lines and primary tumors demonstrated similar or elevated hMOF and
H4K16ac levels. Accordingly, MOF overexpression correlated with increased cellular proliferation, oncogenic
transformation, and tumor growth. Thus, these data reveal that the acetylation of histone H4 at K16 by MOF
is an epigenetic signature of cellular proliferation common to both embryogenesis and oncogenesis and that
MOF is an essential factor for embryogenesis and oncogenesis.
MOF belongs to the MYST family of acetyltransferases,
which have been associated with acute myeloid leukemia
(MOZ), transcriptional silencing in Saccharomyces cerevisiae
(SAS2 and YBF2/SAS3), interactions with human immunode-
ficiency virus Tat in humans (TIP60), and dosage compensa-
tion in Drosophila melanogaster (MOF), in addition to their
role in DNA damage repair (2, 4, 12, 13, 17, 18, 43, 44, 46).
Akhtar and Becker (1) demonstrated that Drosophila MOF is
a histone acetyltransferase that acetylates chromatin specifi-
cally at histone H4 lysine 16 (H4K16). Depletion of human
MOF (hMOF) in human cells results in the loss of acetylation
at lysine 16 of histone H4 (6, 12, 41, 45, 46), strongly arguing
that the highly conserved MOF protein may be the major
histone acetyltransferase, which acetylates histone H4 at K16.
Acetylation at K16 of histone H4 (H4K16ac) is a prevalent
and reversible posttranslational chromatin modification in eu-
karyotes, and recent studies have highlighted its significance.
Shogren-Knaak and coworkers have found that a single histone
H4K16ac modification modulates both higher-order chromatin
structure and functional interactions between a nonhistone
protein and the chromatin fiber (39). Shia and coworkers have
demonstrated that the presence of H4K16ac and H2A.Z syn-
ergistically prevent the ectopic propagation of heterochroma-
tin in the subtelomeric regions of yeast (36). Furthermore, it is
well understood that H4K16ac disrupts higher-order chroma-
tin structure, changes the functional interactions between
chromatin-associated proteins (39), and serves as a switch for
altering chromatin from a repressive to a transcriptionally ac-
tive state in yeast and humans (36). Interestingly, Dou and
coworkers reported that MOF-mediated histone acetyltrans-
ferase activity, specific for H4K16, is required for optimal tran-
scription activation on a chromatin template in vitro and in
vivo (6). The loss of monoacetylation at lysine 16 of histone H4
specifically at nucleosome repetitive sequences is a common
hallmark of tumor cell lines and human cancer where it is
progressively lost from early preneoplastic stages to the most
malignant stage (8). Furthermore, inhibition of SIRT1
deacetylase in breast and colon cancer cells has been shown to
cause increased acetylation of H4K16 at two specific endoge-
nous promoters that correlated with decreased proliferation
(29). In contrast, mouse embryonic fibroblasts (MEFs) defi-
cient for SIRT1, have dramatically increased resistance to
replicative senescence (5). These results demand further eval-
uation of H4K16ac in tumor and normal cells.
Vigorous cellular proliferation is common and essential dur-
ing both embryogenesis and oncogenesis. Therefore, these two
processes may potentially have common chromatin modifica-
tion signatures characteristic of their proliferation status. Re-
cent studies have demonstrated that hMOF depletion, result-
ing in the loss of H4K16 acetylation correlates with a decrease
in DNA damage-induced activation of ATM and prevents
ATM from phosphorylating downstream effectors, such as p53
and CHK2 (12, 45). hMOF physically interacts with ATM and
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p53 (6, 12), and in vitro, hMOF binds to and acts synergistically
with p53 to increase histone H4K16ac and target gene tran-
scription (6). While H4K16ac is known to alter higher-order
chromatin structure into a relaxed conformation (39), it is
important to determine whether there is a correlation between
this modification and cellular growth both during embryonic
development and in the process of tumorigenesis.
In this study, we determined whether MOF, which specifi-
cally acetylates H4K16, is required for cell growth and prolif-
eration during either embryogenesis or tumorigenesis and
whether proliferating tumors and tumor-derived cell lines
demonstrated loss of MOF and H4K16 acetylation. Specifi-
cally, we analyzed the impact of mammalian MOF expression
on embryonic development and oncogenic transformation, two
processes that rely on cellular proliferation. We examined
MOF and H4K16ac levels in single-cell zygotes through blas-
tocyst-stage embryos and found that ablation of MOF corre-
lated with loss of histone H4K16ac and paralleled embryonic
lethality and cell death. Conversely, MOF overexpression in-
creased H4K16ac levels, which correlated with oncogenic
transformation and tumor growth. All tumor cell lines exam-
ined expressed hMOF and H4K16ac. Strikingly, primary hu-
man cells immortalized with the catalytic unit of telomerase
(hTERT) have higher levels of hMOF and H4K16ac than
primary cells do.
MATERIALS AND METHODS
Targeted mutagenesis. Prior mapping and sequence studies indicated the
mouse Mof (mMof) gene is located on chromosome 7 at the end of a subtelo-
meric region (see Fig. 1). An mMof gene-targeting vector was constructed from
129/SvJ mouse DNA by replacing a genomic fragment containing part of exon 2,
intron 2, exon 3, and part of intron 3 with a neomycin resistance gene cassette
(see Fig. 2). A diphtheria toxin A gene cassette was also included in the targeting
construct as negative selection against random integration. The construct was
electroporated into 129/Sv W9.5 embryonic stem (ES) cells, and G418-resistant
colonies were analyzed by Southern blot analysis using a 5 flanking probe. Three
independently derived Mof/ ES cell clones were injected into C57BL/6 blas-
tocysts to derive male chimeras. Germ line transmission of the targeted allele was
confirmed by Southern blot analysis.
A conditional Mof allele was constructed by inserting a single loxP site together
with an FRT-flanked hygromycin resistance gene cassette 1.5 kb upstream of the
mMof transcription initiation site and a second loxP site within intron 3 (see Fig.
5). The construct was electroporated into W9.5 ES cells to generate Mofflox/
cells. Using a knock-in strategy, the tamoxifen-inducible creERT2 fusion gene
cassette (7) was inserted into the ubiquitously expressed ROSA26 locus by ho-
mologous recombination (11). Correctly targeted mMofflox//Rosa26creERT2/ ES
clones were grown in the presence of 200 nM tamoxifen to yield mMofflox//
Rosa26creERT2/ ES cells. Electroporation of these cells with the conditional
targeting vector then gave rise to mMofflox//Rosa26creERT2/ and mMofflox/flox/
Rosa26creERT2/ ES cell clones.
Staging and collecting of oocytes and embryos. Oocytes, fertilized eggs, and
early embryos were collected from mice according to a previously described
procedure (49). Oocytes and embryos were fixed for 20 min in 4% paraformal-
dehyde in phosphate-buffered saline (PBS) and then washed three times with
PBS supplemented with 1% bovine serum albumin (BSA). Fixed oocytes and
embryos were permeabilized in 0.5% Triton X-100 in PBS supplemented with
1% BSA for 25 min, incubated overnight at 4°C in antibody diluted in PBS
supplemented with 1% BSA, then washed to remove nonspecifically bound
antibody, and incubated in 2.5 g/ml Texas Red-conjugated donkey anti-rabbit
immunoglobulin G (IgG) for 1 h at room temperature. The embryos and oocytes
were then placed in 0.4 mg/ml RNase in PBS supplemented with 1% BSA for 10
min and stained and mounted in 4,6-diamidino-2-phenylindole (DAPI) with
glycerol slow-fade mounting medium. Images were obtained on a Zeiss 410
Axiovert system. For each developmental panel, contrast and brightness re-
mained constant. Approximately 40 oocytes/embryos were analyzed for a partic-
ular developmental stage in at least three independent trials, and relevant optical
sections are shown.
Generation of various mouse genotypes. All mice in this study have SV129
background. The Atm and p53 heterozygous mice have been described previously
(33, 50). Atm/ mice are infertile. Atm//Mof/ mice were generated by
crossing male and female Atm//Mof/ genotypes. Offspring were genotyped
at age 21 days by PCR-based assays using mouse tail DNA (50).
Cell lines. The cell lines used were human lymphoblastoid (GM07349,
GM10860, GM10854, GM10863, GM10851, GM10850, and GM10847), human
leukemia (HL60, K562, and Jurkat), mesothelial cancer lines (REN, LRK,
MS1022H, H266, H2052, and H2452), lymphoma (Raji, U937, and HT), breast
(MCF-7 and MCF-10A), colon (HCT-116 and RKO), lung (H1299), osteosar-
coma (MG63) lymphoblastoid cell lines, and 293 and HeLa cells. All cells were
maintained as described previously (26, 40). Primary fibroblast cells lines
(GM5823, HFF, and BJ) and the establishment of their hTERT-derived coun-
terparts were described previously (48). Mouse fibroblasts 435 (with ATM) and
743 (without ATM) cells have been described previously (10).
Survival assay. Cells were plated into 60-mm dishes in 5.0 ml of medium,
incubated for 6 h, and subsequently exposed to ionizing radiation (IR) as described
previously (25). The number of cells plated per dish was selected to ensure that
about 50 colonies would survive treatment with a particular radiation dose. Cells
were exposed to IR in a dose range of 0 to 6 Gy at room temperature. Cells were
incubated for 12 or more days and then fixed in methanol-acetic acid (3:1) prior to
staining with crystal violet. Only colonies containing at least 50 cells were counted.
Western blot analysis. Cell lysates for Western blot analysis were prepared as
previously described (27). Antibodies used to detect MOF, histone H4, and
acetylated H4K16 were previously described (12). Immunoblotting and detection
of MOF, histone H4, and acetylated H4K16 were done according to previously
described procedures (12, 27, 35).
Primary cell culture, establishment of cell lines, and growth assays. MEFs
from mMof heterozygous intercrosses were isolated from embryonic day 13.5
(E13.5) embryos by standard procedures (15, 25). Cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum
(FBS) and frozen at different passages for storage. Continuous passaging was
utilized to allow for emergence of spontaneously immortalized clones from both
wild-type and mMof heterozygous MEFs. These clones were positive for telo-
merase activity and were passaged for at least 100 population doublings.
For growth assays, MEFs were plated in 60-mm tissue culture dishes, and four
dishes were counted on the indicated days. Four different passages (passages 1,
5, 12, and 19) were utilized in order to determine the effect of passage number
on growth rate. To determine plating efficiency, MEFs were seeded at various
densities, and after 15 days in culture, the colonies were fixed, stained, and
counted.
Analysis of micronuclei and ratio of normochromatic to polychromatic eryth-
rocytes. Micronucleus formation and the ratio of normochromatic to polychro-
matic erythrocytes were determined by previously described procedures (15, 23).
Briefly, bone marrow smears from the mice were prepared, and the stained
smears were examined to determine the incidence of micronucleated cells in
1,800 polychromatic erythrocytes and the ratio of normochromatic to polychro-
matic erythrocytes for each animal.
Transformation assay. The transformation assay was performed as described
previously (9, 15). Exponentially growing subconfluent cells were trypsinized and
plated 48 h prior to exposure to IR at a dose of 1 Gy. Immediately after
irradiation, the cells were trypsinized and replated into 10-cm-diameter culture
dishes at cell numbers estimated to result in either 300 viable cells per dish for
the assay of neoplastic transformation or 30 viable cells for the cell survival assay.
For the assay of neoplastic transformation, cells were grown in Eagle’s basal
medium supplemented with 10% heat-inactivated FBS, and the culture medium
was changed at 12-day intervals during the 6- to 8-week incubation. Cells plated
for cell survival determination were incubated as described above. At the end of
12 or 42 days of incubation, cells were fixed in formalin and stained with Giemsa.
Cell survival was determined by the colony assay as described above, while
neoplastic transformed foci II and III were identified according to the criteria of
Reznikoff et al. (30, 31).
Reverse transcriptase PCR of hMOF mRNA. To compare hMOF mRNA
levels in paired tumor and normal tissue samples, reverse transcriptase PCR was
performed. mRNAs isolated from paired tumor and normal tissue samples were
obtained from the Alvin J. Siteman Cancer Center of the Washington University
School of Medicine, St. Louis, MO; the Sidney Kimmel Cancer Center at John
Hopkins, Baltimore, MD; and the M.D. Anderson Cancer Center, Houston, TX.
The isolated RNAs from tumor and normal tissues were treated with RNase-free
DNase (Roche Diagnostic Corporation, Indianapolis, IN) (1 mg/ml) for 2 h at
37°C, followed by heat inactivation at 65°C for 10 min. The reverse transcriptase
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reaction mixture contained 1 mg/ml DNase-treated RNA, 0.25 mg/ml pdN6
random primers (Roche Diagnostic Corporation), first-strand buffer (GIBCO-
BRL), 0.5 mM deoxynucleoside triphosphate (Roche Diagnostic Corporation,
Indianapolis, IN), and 200 units Moloney murine leukemia virus reverse trans-
criptase (GIBCO-BRL), and the mixtures were incubated for 1 h at 37°C. PCR
was performed by using gene-specific primers along with the primers for -actin.
cDNAs of paired samples (tumor and normal tissue) were analyzed with ABI
Prism 7700 (Applied Biosystems) with SYBR green ROX mix (Abgene, United
Kingdom). Each cDNA was analyzed in triplicate, and dihydrofolate reductase
(DHFR) was used as an internal control for comparison of the expression status.
The relative quantification of hMOF mRNA (compared to DHFR mRNA) was
determined as described previously (34, 35). The primer oligonucleotide se-
quences used for hMOF and DHFR quantification are available upon request.
The products of the reverse transcriptase PCRs were analyzed by gel electro-
phoresis, and they gave single bands of the appropriate amplicon size.
Mice and tumor irradiation. Eight-week-old NMRI nu/nu male mice were
maintained in a pathogen-free mouse colony for the duration of experiments.
Mice were randomly distributed four per cage, and each mouse was labeled with
a code on the ear. Two million exponentially growing RKO cells with and without
hMOF overexpression in a volume of 20 l were injected (intramuscularly) in the
right thigh flank, and the mice were checked daily for tumor appearance as
described previously (32). Animals with a tumor of 8 mm in mean diameter were
locally irradiated with a single dose of 25 Gy using a 8-MeV linear particle
accelerator (dose rate of 1 Gy/min). For the regrowth of tumors, the previously
described protocol was followed (32).
Chemotaxis assay. Migration assays were done in 24-well cell culture cham-
bers with 8-m-pore membranes. The lower surface of the membrane was pre-
coated with fibronectin (25 g/ml). Cells were resuspended in chemotaxis buffer
(DMEM, 0.1% bovine serum albumin, 12 mM HEPES) at 2.5 106 cells/ml, and
150 l of cells from each sample was loaded into the upper chamber. Chemotaxis
buffer (0.6 ml) containing DMEM, 10% FBS, epidermal growth factor (EGF)
(20 ng/ml), and insulin growth factor (IGF) (20 ng/ml) was dispensed into the
lower chamber. The plates were incubated for 24 h at 37°C in 5% CO2. After
incubation, the inserts were removed carefully, and the cells were fixed and
stained using the HEMA 3 staining kit (Fisher Scientific Company, MI). Mi-
grated cells were counted in a minimum of five high-power fields (magnification
of 100).
RESULTS
Loss of MOF and H4K16 acetylation results in early em-
bryonic lethality. MOF mRNA is expressed ubiquitously in all
human tissues (Fig. 1A). The mouse Mof gene (mMof) local-
izes on chromosome 7 (Fig. 1B) and encodes a protein product
of 58 kDa, a molecular mass similar to that of human MOF
protein (Fig. 1C) (12, 42). To determine the physiological
significance of mammalian MOF, we disrupted the mMof gene
by homologous recombination in embryonic stem cells (Fig.
2A) and generated germ line-transmitting chimeras.
Heterozygous (mMof/) intercrosses yielded wild-type
(mMof/) and heterozygous (mMof/) offspring pups but no
homozygous mMof null mutant pups (Fig. 2B). The complete
absence of homozygous Mof null mutants in all litters exam-
ined implied that Mof deficiency is lethal to embryos (Fig. 2B).
We then determined the stage of lethality by analyzing em-
bryos from mMof/ intercrosses at different times postco-
itum. In the litters of mice at E7.5 and E8.5 that we dissected,
we found approximately 25% empty or necrotic deciduae (Fig.
2C), and all the morphological normal embryos were either
wild type or heterozygous (Fig. 2D and data not shown). At
E7.5, all the normal embryos (wild type and heterozygotes) had
gastrulated, while the Mof null mutant deciduae contained
clusters of cells within a small sac or some giant cells only (Fig.
2C), indicating that Mof-deficient embryos are capable of im-
plantation but die prior to the onset of gastrulation.
The observation that no viable mMof/ embryos are found
at the E7.5 stage of development led us to investigate the
expression and localization of MOF protein and H4K16ac sta-
tus during early embryogenesis (single-cell zygote to preim-
plantation blastocyst) (Fig. 3A). PCR-based genotyping re-
vealed that about 25% of all zygotes did not have the mMof
gene (Fig. 3B). MOF protein localized throughout the entire
zygotic cell (whether mMof/, mMof/, or mMof/), in-
cluding the cytoplasmic and chromatin regions, indicating a
strong maternal contribution of MOF. In the single-cell zy-
gotes, both male and female pronuclei chromatin in the fertil-
ized egg stained equally strongly for acetylated histone H4K16
(H4K16ac) (Fig. 3C, top panel). All zygotes were positive for
MOF and H4K16ac staining; however, about 25% of the zy-
gotes did not have the mMof gene (Fig. 3B). Through the first
few cleavages, until the 16-cell stage embryo is reached, neither
MOF nor H4K16ac immunofluorescence distinguishes
mMof/ embryos from the mMof/ or mMof/ embryos
(Fig. 3C and D). This is most likely due to the abundance of
maternal MOF protein present in mMof/ oocytes, which
probably allowed for continued cleavage during early embry-
onic development and normal levels of H4K16ac in the chro-
FIG. 1. mRNA expression levels, gene localization, and mMof gene product weight. (A) Northern blot of multiple normal human tissues
hybridized with an hMof cDNA probe. (B) Fluorescence in situ hybridization localization of the mMof gene by in situ hybridization of biotin-labeled
mMof genomic DNA to the mouse metaphase chromosome. Specific signal is observed at the subtelomeric region of the chromosome 7.
Chromosome 7 was identified by the standard G-banding. (C) In vitro expression of a cloned mMof cDNA. Translation products were loaded onto
a 10% sodium dodecyl sulfate-polyacrylamide gel and separated by electrophoresis. The autoradiograph shows the following: no cDNA added
(lane 1), luciferase control cDNA (lane 2), and mMof cDNA (lane 3). The positions of a set of prestained protein size markers (Cambrex) (in
kilodaltons) are indicated to the left of the gel. The mMof product is indicated by the arrow to the right of the gel.
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matin. At the 32-cell stage, mMof/ or mMof/ embryos
have increasingly distinct nuclear signals for MOF (Fig. 3D,
top panel). H4K16ac levels in Mof null mutants at this stage
remained unaffected compared to the levels in heterozygous or
wild-type embryos.
Starting at the morula stage, marked differences between
mMof/ and mMof/ embryos become apparent. As the
maternal MOF diminishes, acetylation of H4K16 becomes un-
detectable from this stage (Fig. 3E). MOF protein and
H4K16ac are barely detectable in mMof/ embryos at the
blastocyst stage of development (Fig. 3F). Very interestingly,
some cells of the mMof/ late morula stage express higher
levels of MOF and higher levels of H4K16ac (Fig. 3E, top
panel), a pattern seen among several embryos at this stage. The
polarized configuration of these cells and the upcoming differ-
entiation of trophectoderm and inner cell mass (ICM) (Fig.
3F) suggest that these cells may be the progenitors of the ICM.
This is further substantiated by the appearance of differenti-
FIG. 2. mMof inactivation results in early embryonic lethality. (A) Gene targeting strategy for mMof null allele. The organization of the
wild-type gene, the targeting construct, and the structure of the locus following gene targeting are shown. Exons are shown as black boxes and are
numbered. The locations of PCR primers for detecting gene targeting events are shown by arrows at the bottom of targeted mMof mutant locus.
The locations of the phosphoglycerate kinase gene carrying a neomycin resistance gene (PGKneopA) and the diphtheria toxin A gene (DT) are
shown. The restriction sites shown are BglII (B), EcoRI (E), SphI (S), and XbaI (X). (B) Southern blot analysis of tail DNA digested with BglII
and hybridized with a probe located outside the targeting construct. Tail DNA from mMof/ (/) and mMof/ (/) mice was used. Note
the absence of mMof/ mice. The positions of molecular size markers in lane M (in kilobases) are indicated to the right of the gel. (C) Gross
morphology of embryos. Two normal (left and right) and three mutant embryos at E7.5 (arrows). (D) All normal embryos at E8.5 were either
mMof/ or mMof/ as judged by CD31 staining, which detects vasculature of endothelial cells. Genotypes were confirmed by PCR analysis.
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ated trophoblasts and pluripotent undifferentiated ICM cells in
the mMof / blastocyst (Fig. 3F). ICM cells have convincingly
higher levels of MOF protein than trophectoderm cells, and
they also have higher levels of H4K16ac. These observations
are consistent with previous results with regard to the higher
levels of H4K16ac in ES cells compared to trophectoderm
(21). The increased acetylation of H4K16 in ES cells is sug-
gestive of the significance of this chromatin modification for
rapid proliferation during early embryonic development. Even-
tually, complete depletion of MOF and loss of H4K16ac from
a few blastocysts (following Mendelian ratios) was observed
(Fig. 3F and data not shown). This correlated with the embryos
exhibiting a marked delay in developmental progression, slug-
gish hatching and implantation, proliferation arrest, and death
before gastrulation. These embryos were identified by geno-
typing as mMof null embryos (data not shown). Retarded de-
velopmental progression became more evident as the embryos
reached the blastocyst stages (Fig. 3F). Curiously, both the
interphase chromatin and metaphase/anaphase chromosomes
show comparable H4K16ac levels that are confined to the
DAPI-stained DNA regions (Fig. 3F). A similar phenomenon
was reported for H4K16ac in Drosophila (19). The deformed
nuclear morphology observed by DAPI staining in the
mMof/ blastomeres at the morula stage and also the blasto-
cyst stage (Fig. 3F) could be a precursor of the upcoming
catastrophic effects on development.
Inactivation of ATM and p53 does not rescue lethality of
mMof deletion. Prior studies have reported that depletion of
hMOF resulted in a G2/M arrest (46) that could be partly
rescued by inactivation of specific cell cycle checkpoint gene
products. Therefore, we examined whether the delayed devel-
opmental progression and lethality of mMof/ embryos could
be rescued by inactivating genes such as ATM or p53, which are
involved in cell cycle control (20, 22, 27, 38). Although knock-
down of hMOF in human cells results in a G2/M checkpoint
arrest (46), inactivation of ATM or p53 could not rescue or
ameliorate the early embryonic lethality of mMof nullizygous
embryo (data not shown). We determined the influence on
growth due to mMof haploinsufficiency in Atm heterozygous
and Atm null backgrounds by monitoring the health and sur-
FIG. 3. Dynamics of MOF and H4K14Aac during early embryogenesis. (A) Cell proliferation of fertilized zygotes. Some zygotes showed large
and slow proliferation as indicated by the white arrow. (B) PCR-based genotyping of zygotes from intercrosses of mMof/ mice. (C) Maternally
expressed MOF and H4K16acetylation in one-, two-, and eight-cell embryos. (D) mMof null embryos still have maternal MOF and H4K16ac until
the 32-cell stage. (E) Reduced MOF and H4K16ac in the morula stage of mMof null embryos compared to the corresponding wild-type embryos.
(F) mMof null blastocysts differentiated into inner cell mass (ICM) and trophoblasts show loss of MOF and H4K16ac. Note that in the wild-type
blastocysts, MOF and H4K16ac staining is more intense in ICM cells than in trophectoderm cells. The arrows point to the H4K16ac-positive
metaphase cell. DIC, differential interference contrast.
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vival of mMof//Atm/ (n 	 34), mMof//Atm/ (n 	
45), mMof//Atm/ (n 	 30), mMof//Atm/ (n 	 38),
mMof//Atm/ (n 	 24), and mMof//Atm/ (n 	 19)
mice over a period of 1 year (Fig. 4A). In contrast to 92% of
mMof//Atm/, mMof//Atm/, or mMof//Atm/
mice, only 76% mice with the mMof//Atm/ genotype
remained healthy and survived the first year of life. mMof
heterozygosity in Atm null background (mMof//Atm/) re-
sulted in a modest weight reduction and earlier death com-
pared to Atm null mice (Fig. 4A and B). Although the differ-
ences in survival are modest, they are statistically significant
(P 
 0.05). Interestingly, mMof heterozygosity in a p53-defi-
cient background (mMof//p53/) resulted in death at an
earlier age compared to p53 null mice (Fig. 4C and data not
shown).
Reduced mMof levels correlate with decreased H4K16ac,
cell proliferation, cell survival, and increased genomic insta-
bility. To examine the biological function of mMof at the
cellular level, we attempted to generate homozygous mutant
ES cells by increasing the G418 concentration to force homo-
genetization and by sequential gene targeting of mMof/ ES
cells using a mMof-hygromycin resistance gene vector (data not
shown). However, no homozygous mMof/ ES cells could be
obtained, suggesting that Mof function is indispensable for
viability and/or proliferation of ES cells.
Thus, we designed a conditional mMof allele (Mofflox) by
flanking exons 1 to 3 with loxP sites (Fig. 5A) and generated
mMofflox/ ES cells. To inactivate the conditional allele by
cre-mediated recombination, we introduced the tamoxifen-in-
ducible creERT2 fusion gene into the ROSA26 locus
(ROSA26creERT2/) using a knock-in strategy and subsequently
generated mMofflox//Rosa26creERT2/ and mMofflox/flox/
Rosa26creERT2/ ES cells. The phenotypic consequences of
MOF deficiency were then determined by tamoxifen-induced
expression of Cre recombinase and inactivation of the condi-
tional Mofflox allele (Fig. 5A and B). Deletion of mMof re-
sulted in the subsequent loss of MOF protein, loss of acetyla-
tion of histone H4 at K16 (Fig. 5C), and decreased cellular
proliferation (Fig. 5D). Heterozygous mMof (mMof/) MEFs
also had reduced levels of MOF (Fig. 6A) and demonstrated a
modest increase in population doubling time (Fig. 6B), de-
creased IR-induced -H2AX focus formation (Fig. 6C), and a
slight decrease in survival after IR exposure (Fig. 6D). The
decreased survival in mMof/ MEFs could be due to defec-
tive repair of IR-induced single- and double-strand DNA
breaks. MOF, a chromatin-modifying factor, may have a crit-
ical role in the repair of DNA cross-links. We also compared
the effect of mitomycin C-induced DNA cross-links on
mMof / and mMof / MEFs. Cell killing after mitomycin C
treatment was higher in mMof/ MEFs than in mMof/
MEFs (Fig. 6E).
One mechanism that could contribute to the altered growth
characteristics of haploinsufficient mMof cells is increased
genomic instability. This was substantiated by the observation
of a modestly increased ratio of normochromatic to polychro-
matic erythrocytes and an increased frequency of micronucleus
occurrence in erythrocytes from mMof/ mice compared to
mMof/ mice (Table 1). The higher frequency of spontaneous
micronucleus formation observed in mMof/ mice is consis-
tent with the higher spontaneous chromosome aberration rate
observed in cultured mMof/ MEFs and in phytohemagglu-
tinin-stimulated lymphocytes isolated from mMof/ mice
(Table 2 and data not shown). A reduced level of IR-induced
-H2AX focus formation was also observed in heterozygous
mMof cells compared to wild-type mMof cells. Interestingly,
reduced levels of mMof increased genomic instability and de-
creased survival after IR or mitomycin C exposure, while total
loss resulted in cell lethality.
FIG. 4. Influence of mMof heterozygosity on the survival of mice
with different genotypes. (A and B) Body weight (A) and cumulative
survival (B) of Atm//Mof/, Atm//Mof/, Atm//Mof/,
Atm//Mof/, and Atm//Mof/ mice. The mice were weighed
weekly from weaning (21 days) to adulthood. The differences in the
weight and survival of Atm//Mof/ and Atm//Mof/ mice are
modest, but the differences are statistically significant (P 
 0.05 de-
termined by the chi-square test). (C) Cumulative survival of p53//
Mof/, p53//Mof/, p53//Mof/, p53//Mof/, and p53//
Mof/ mice. The cumulative survival was plotted according to
Kaplan-Meier analysis.
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FIG. 5. mMof is essential for proliferation and/or viability of ES cells. (A) Conditional inactivation ofmMof. A partial restriction map of the genomic region
containing mMof exons 1 to 4 (black boxes numbered 1 to 4) is shown at the top, followed by a diagram of the targeting vector used for insertion of the
FRT-flanked neomycin cassette and loxP sites into the mMof gene (bottom). A diphtheria toxin A gene cassette is also included in the targeting construct as a
negative selection marker. The wavy line represents plasmid sequence. The restriction sites shown are BglII (B), EcoRI (E), SalI (S), and SphI (Sp). (B) Southern
blot analysis showing cre-mediated recombination of the floxed allele in mMofflox//Rosa26creERT2/ and mMofflox/flox/Rosa26creERT2/ ES cells after tamoxifen
treatment. Genomic DNA was prepared from mMofflox/flox/Rosa26creERT2/ (lanes 1, 3, 4, 7, 8, 11, 12, 15, and 16) or mMofflox//Rosa26creERT2/ ES cells (lanes
2, 5, 6, 9, 10, 13, 14, 17, and 18) collected at 0, 24, 36, 48, and 60 h from cells treated with 200 nM tamoxifen (Tam) or not treated with tamoxifen (), digested
with PstI, and probed with the 5 external probe. Note that after 24 h, the conditional (Cond) Mofflox allele is fully recombined in the presence of tamoxifen. The
positions of molecular size markers in lane M (in kilobases) are indicated to the left of the gel. WT, wild type. (C) Western blot analysis for MOF and H4K16ac
levels in mMofflox/flox/Rosa26creERT2/ ES cells harvested at 0, 24, 48, and 60 h from cells treated with tamoxifen (Tam) () or not treated with tamoxifen ().
(D) Proliferation of mMofflox//Rosa26creERT2/ and mMofflox/flox/Rosa26creERT2/ ES cells with or without tamoxifen treatment. Cell numbers were determined
at different time points to determine the population doublings in cells with and without mMof.
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MOF levels correlate with the frequency of oncogenic trans-
formation. One of the hallmarks of malignant transformation
is genomic instability, which promotes a wide range of muta-
tions, including structural and numerical alterations of chro-
mosomes. In order to gain further insight into the function of
mammalian MOF during oncogenesis, we examined cells ex-
pressing either mutant (mMof [Fig. 7A and unpublished
data]) or wild-type mMof for IR-induced cell killing and on-
cogenic transformation. Cells expressing ectopic mMof have
higher levels of mMof and H4K16ac than cells expressing
mMof do (Fig. 7B). Cells expressing mMof had decreased
survival (Fig. 7C) and reduced spontaneous and IR-induced
oncogenic transformation rates compared to cells overexpress-
ing mMof (Fig. 7D) as determined by focus formation de-
scribed previously (15). We also determined the levels of
mMof and H4K16ac in mouse tumors and normal tissues
FIG. 6. Haploinsufficiency of mMof influences the DNA damage response. (A) Comparison of mMof levels in mouse embryonic fibroblasts
established from wild-type (mMof/) and heterozygous (mMof/) mMof embryos. (B) Population doubling time of heterozygous mMof MEFs
and wild-type MEFs. ATM-deficient MEFs are used as a positive control. (C) -H2AX focus formation after exposure to radiation (1 Gy).
(D) Heterozygous mMof/ cells are more sensitive to increased doses of IR exposure (4 Gy) than wild-type mMof/ cells are, and the
differences are statistically significant (P 
 0.05 determined by chi-square test). (E) Survival after mitomycin C treatment. More mMof/ cells are
killed compared to mMof/ cells, and the differences are statistically significant (P 
 0.001, as determined by the chi-square test).
404 GUPTA ET AL. MOL. CELL. BIOL.
 o
n
 January 11, 2014 by W








and found that tumor tissues have increased levels of MOF and
H4K16ac in comparison to normal tissues (Fig. 7E).
Cells with prolonged life span have higher hMOF and
H4K16ac levels. A prerequisite for oncogenic transformation
is the acquisition of prolonged life span. Since most immortal-
ized cells and tumors have telomerase activity (16) and expres-
sion of the catalytic unit of telomerase (hTERT) prolongs the
life span of primary fibroblasts (3, 47, 48), we determined
whether MOF levels change in cells with a prolonged life span.
hMOF levels were compared in isogenic cells with and without
hTERT expression. Comparison of hMOF and H4K16ac levels
in these isogenic cell lines revealed that hMOF and H4K16ac
levels are higher in cells where life span has been prolonged by
ectopic expression of hTERT (Fig. 8A).
Tumors and tumor-derived cell lines have not lost MOF
expression and H4K16ac levels. As hMOF is required for
acetylation of H4K16 and cellular proliferation, we compared
hMOF expression in various tumors and normal tissues. Con-
sistent with the higher levels of hMOF seen in rapidly prolif-
erating cells, hMOF mRNA expression was detected in all of
the 300 different breast (n 	 132), lung (n 	 74), and prostate
(n 	 94) tumors examined (Fig. 8B and data not shown).
Irrespective of tumor type, approximately 25 percent of normal
tissue samples had reduced levels of hMOF mRNA expression
than the corresponding tumor tissue sample did (Fig. 8B and
data not shown). However, hMOF protein and H4K16ac were
found in the entire tumor and immortalized cell lines examined
(Fig. 8C and D and data not shown). Tumor cells consistently
demonstrated higher levels of mMof and H4K16ac, further
supporting the notion about the relationship between the sta-
tus of H4K16ac status and cellular proliferation.
MOF levels correlate with tumor growth. To determine
whether hMOF levels influence tumor growth, we used a stan-
dard nude mouse xenograft assay to examine tumor growth and
its response to IR exposure. Knockdown of hMOF in colorectal
carcinoma (RKO) cells (Fig. 9A) inhibited cell growth. Con-
versely, overexpression of hMOF increased H4K16ac (Fig. 9B)
and accelerated proliferation (Fig. 9C). RKO cells, with or with-
out overexpression of hMOF, were injected into mice, and when
the tumors reached 8 mm in size, the tumors were locally irradi-
ated with a single 25-Gy dose. Untreated tumors arising from
injected RKO cells overexpressing hMOF grew rapidly compared
to control cells (Fig. 9D). Tumors from RKO cells, with and
without hMOF overexpression, grew at relatively constant rates,
whereas radiation treatment (single dose of 25 Gy) caused tem-
porary shrinkage of the tumors, followed by regrowth in most of
the tumors. Interestingly, tumors from RKO cells with hMOF
overexpression regrew faster than control cells. Two months after
irradiation, 20% of the tumors from control cells were below
detectable levels compared to only 8% tumors derived from
cells overexpressing hMOF. An immediate relapse of tumor
growth was much more prominent in cells expressing hMOF.
These results suggest that hMOF promotes tumor growth.
We also tested whether hMOF could influence cell migra-
tion. RKO cells with and without hMOF overexpression were
subjected to a chemotaxis assay conducted in the presence and
absence of EGF and IGF, factors shown to induce chemotaxis
in various cell types. FBS (10%) was utilized as a positive
control. Both cell types migrated towards 10% FBS, but there
was a modest enhancement of migration capability in cells
overexpressing hMOF compared to control cells (Fig. 9E).
Cells overexpressing hMOF also showed significantly increased
migration towards both EGF and IGF compared to control
cells. These results are consistent with a role for MOF in
oncogenesis.
DISCUSSION
There are two known histone acetyltransferase complexes
that modify histone H4 at K16; the MSL (male-specific silenc-
ing) complex in humans and flies, and the SAS (something
about silencing) complex in yeast cells (1, 13, 41). The MSL
complex specifically acetylates H4K16 in Drosophila and hu-
mans. In human cells, knockdown of hMOF results in the loss
of H4K16ac (12, 41, 46). H4K16 acetylation has been shown to
destabilize nucleosomes and correlates with regions of chro-
matin decondensation (39). Here, we report the first extensive
study showing that MOF is required for proliferation during
embryogenesis and in oncogenesis. However, the exact role of
MOF in these processes remains to be determined. An intrigu-
ing possibility is that MOF acetylation of histone H4 at K16
may have a regulatory role during transcription (1), which is
poorly understood in mammals, but well documented in yeast
and Drosophila (36, 37). The significance of H4K16 acetylation
lies in the fact that in budding yeast, most of the genome exists
in a decondensed state with more than three fourths of histone
H4 acetylated at lysine 16 (28, 37). In Drosophila, the tran-






















mMof/ 3 5 8 2
mMof/ 10 15 19 8
a Chromosome gaps and breaks, chromatid gaps and breaks, and chromosome
end associations were analyzed at metaphase, and bridges were analyzed at
anaphase in cells with and without haploinsufficient mMof. The aberrations in
mMof/ haploinsufficient cells are significantly different from mMof/ cells as
assessed by chi-square analysis (P 
 0.05, as determined by the chi-square test).
TABLE 1. Ratio of normochromatic erythrocytes to polychromatic
erythrocytes and micronucleus formation









Mean Range Mean Range
mMof/ 1.49 0.43–2.88 1.06 0–3.69
mMof/ 1.68 0.51–3.19 1.22 0–3.90
a Six age-matched sets of male and female mMof/ and mMof/ mice were
sacrificed, and bone marrow smears were made as described previously (24).
mMof/ mice have a modest increase in the ratio of normochromatic erythro-
cytes to polychromatic erythrocytes and a higher frequency of micronucleated
cells than mMof/ mice do. The differences in the ratio of normochromatic
erythrocytes to polychromatic erythrocytes and the higher frequency of micro-
nucleated cells among Mof/ and Mof/ mice are statistically significant (P 

0.05, as determined by the chi-square test).
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scriptionally enhanced X chromosome of male flies, a site of
ubiquitous H4K16ac, is also decondensed (1). In human cell
lines, decreased levels of hMOF correlate with loss of
H4K16ac and is associated with defective DNA repair (12). In
this study, we found that the loss of H4K16ac correlated with
the progressive depletion of maternal MOF during embryo-
genesis in mMof null embryos. In wild-type mMof embryos, the
rapidly proliferating ICM cells have convincingly higher levels
of MOF protein than trophectoderm cells, which is consistent
with previous results showing higher levels of acetylated
H4K16 in ES cells than in trophectoderm cells. Thus, increased
acetylation of H4K16 in ES cells is indicative of the significance
of this chromatin modification for proliferation during devel-
opment. Complete ablation of MOF and loss of H4K16ac
results in a marked delay in developmental progression, slug-
gish hatching and implantation, proliferation arrest, and death.
The loss of cell proliferation could be due to cell cycle arrest
specifically induced by p53 and by ATM as suggested by a
previous report of G2/M arrest in hMOF knockdown cells (46).
In addition, hMOF has been reported to acetylate p53 at lysine
120, and this acetylation may help distinguish between the cell
cycle arrest and apoptotic functions of p53 (45). If the mMof
depletion-dependent cell cycle arrest were the cause of embry-
onic lethality or cellular death, then depletion of p53 or ATM
should have rescued or at least partially ameliorated the ob-
served embryonic lethality. However, our results do not sup-
port this hypothesis.
Inactivation of the mMof gene in ES cells caused depletion
FIG. 7. The level of mMof protein correlates with cell survival and oncogenic transformation. (A) Strategy for cloning the mMof gene and its
domains. mMof protein is denoted at the top with a line representing 458 amino acids. Five different fragments of mMof cDNA encoding full-length
mMof protein with three domains (chromodomain region, zinc finger, and acetyl coenzyme A (acetyl Co-A) binding site) are diagrammed. The
five different fragments were generated by PCR using specific primers. All clones are drawn to approximate scale. Each fragment is subcloned into
pBABE retroviral or pcDNA3.1 vectors. The fragment designated mMof showed dominant-negative activity for cell survival and was used in
transformation assays. (B) Western blot analysis to determine the levels of MOF and H4K16ac in mouse 435 and 743 fibroblasts used in the analysis
of the assays shown in panels C and D. 435 fibroblasts are mouse cells with wild-type ATM, while 743 fibroblasts are ATM null cells. Lanes 1, 3,
and 4 are 435 cells transfected with the described cDNAs. HeLa cell extracts were used as a positive control for detection of MOF protein in mouse
cell lines. In panels B and C, the control is 435 mouse fibroblasts. (C) Cell survival of 435 fibroblasts transfected with empty vector, 435 fibroblasts
expressing wild-type mMof or mMof, and 743 cells (positive control) determined by colony-forming assay. (D) Transformation incidence
following exposure to 1 Gy of gamma rays in 435 (Atm/) mouse cells, 435 cells with empty vector, 435 cells with wild-type mMof, and 435 cells
with mMof expression. The spontaneous and IR-induced morphological transformation of 435 cells with and without overexpression of mMof
was determined as described previously (15). (E) Levels of MOF and H4K16ac in normal thymus (N) and tumor tissues (T1 and T2) from mice.
T1 and T2 are samples of two different thymic lymphomas.
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of Mof protein accompanied with loss of acetylated H4K16
and resulted in reduced proliferation and ultimately cell death.
Taken together with the lack of success in deriving homozy-
gous Mof mutant ES cells, these experiments strongly suggest
that Mof function is indispensable for cellular proliferation
and/or viability. These results also raised the question of
whether tumor cells can survive in the absence of MOF and the
associated loss of H4K16 acetylation.
Multiple assays were utilized previously to quantitate H4K16
monoacetylation at the global level and genome region/locus-
specific level, and the data suggested that loss of monoacety-
lation at H4K16 occurs in tumors and tumor-derived cell lines
(8). Our results, however, demonstrate that tumors and tumor-
derived cell lines have similar or higher levels of hMOF or
H4K16ac compared to those of normal control cells (Fig. 7E
and 8 and data not shown). Similar results were found in
multiple different transformed cell lines (Fig. 8 and data not
shown). Moreover, we found that primary cells have lower
levels of hMOF and H4K16ac than the corresponding isogenic
hTERT immortalized cells do (Fig. 8A). These in vitro results
were also supported by the in vivo hMOF expression analysis
of 300 different tumors, which demonstrated no loss of hMOF
expression. In addition, tumor cells with higher levels of hMOF
had faster initial growth and immediate regrowth (recurrence)
of tumors after irradiation exposure (Fig. 9D), suggesting that
hMOF promotes cellular proliferation. Therefore, after exam-
ination of a large number of tumor-derived cell lines and tu-
mor samples, we propose that hMOF and H4K16ac may be
required for the process of transformation, either in vitro or in
vivo.
Intriguingly, MOF overexpression was associated with both
increased K16H4 acetylation and increased cell proliferation
(12, 46; also the present study), while cells treated with SIRT1
inhibitors had increased K16H4 acetylation levels but a reduc-
tion in cell proliferation (29). Thus, although MOF seems to be
closely associated with cell proliferation, the relationship be-
tween the H4K16 acetylation status and cell proliferation re-
quires further study.
The loss of MOF and H4K16ac correlates with increased
genomic instability (Tables 1 and 2 and Fig. 6) (12, 46), which
is considered an important step in cancer development because
it can greatly accelerate the genetic changes leading to tumor
cell progression (14). However, induction of genomic instabil-
ity and increased radiosensitivity caused by depletion of MOF
result in decreased oncogenic transformation, whereas overex-
pression of MOF resulted in increased oncogenic transforma-
tion (Fig. 7C and D); this suggests that the loss of MOF is
probably not a marker of oncogenesis.
Collectively, our data suggest that the requirement for MOF
during tumor cell proliferation is similar to that during embryo-
genesis prior to tissue differentiation. The role of MOF in
cellular proliferation is supported by the following. (i) There is
a strong correlation observed between the ectopic expression
of the catalytic unit of telomerase (hTERT) and the levels of
hMOF and H4K16ac seen in isogenic cell systems (Fig. 8A).
(ii) Depletion of MOF results in cellular lethality. (iii) Over-
expression of MOF results in enhanced oncogenic transforma-
tion and faster relapse of tumor growth after radiation treat-
ment (Fig. 7D and 9D and E). Thus, the results suggest that
expression of hMOF and acetylation of H4K16 are linked with
proliferation status and is supported by the fact that all the
tumor-derived cell lines and immortalized cell lines examined
have both hMOF and acetylated H4K16. These novel obser-
vations presented here provide a foundation for future molec-
FIG. 8. hMOF and H4K16ac levels in primary cells and tumor cell lines. (A) hMOF and H4K16ac levels in human fibroblasts with and without
ectopic expression of hTERT and in tumor cell lines. (B) Comparison of hMOF RNA levels in different tumors and normal tissues: breast (a), lung
(b), and prostate (c). (C and D) hMOF and H4K16ac levels in different tumors (C) and immortalized cell lines (D).
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ular studies on the significance of epigenetic modifications in
varied contexts of embryonic development, tumorigenesis, and
DNA metabolism.
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